Lipid raft disruption as an opportunity for peripheral analgesia

Chronic pain conditions are unmet medical needs, since the available drugs, opioids, non-steroidal anti-inflammatory/analgesic drugs and adjuvant analgesics do not provide satisfactory therapeutic effect in a great proportion of patients. Therefore, there is an urgent need to find novel targets and...

Full description

Saved in:
Bibliographic Details
Published in:Current opinion in pharmacology 2024-04, Vol.75, p.102432-102432, Article 102432
Main Authors: Nehr-Majoros, Andrea Kinga, Király, Ágnes, Helyes, Zsuzsanna, Szőke, Éva
Format: Article
Language:English
Subjects:
Analgesia
Analgesics - pharmacology
Analgesics - therapeutic use
Analgesics, Opioid - therapeutic use
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Chronic Disease
Humans
Ion Channels - therapeutic use
Pain - drug therapy
Pain - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chronic pain conditions are unmet medical needs, since the available drugs, opioids, non-steroidal anti-inflammatory/analgesic drugs and adjuvant analgesics do not provide satisfactory therapeutic effect in a great proportion of patients. Therefore, there is an urgent need to find novel targets and novel therapeutic approaches that differ from classical pharmacological receptor antagonism. Most ion channels and receptors involved in pain sensation and processing such as Transient Receptor Potential ion channels, opioid receptors, P2X purinoreceptors and neurokinin 1 receptor are located in the lipid raft regions of the plasma membrane. Targeting the membrane lipid composition and structure by sphingolipid or cholesterol depletion might open future perspectives for the therapy of chronic inflammatory, neuropathic or cancer pain, most importantly acting at the periphery.
ISSN:1471-4892
1471-4973
DOI:10.1016/j.coph.2024.102432